![Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.9b01924/asset/images/large/jm9b01924_0027.jpeg)
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry
![Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/371/2/487/F1.large.jpg)
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics
![Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective](https://www.frontiersin.org/files/Articles/551365/fphar-11-01078-HTML/image_m/fphar-11-01078-g001.jpg)
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
![The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review](https://openpainjournal.com/contents/volumes/V13/TOPAINJ-13-7/TOPAINJ-13-7_F1.jpg)
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
![NorBNI and morphine induce ROS production via JNK and PRDX6. MycKOR a,... | Download Scientific Diagram NorBNI and morphine induce ROS production via JNK and PRDX6. MycKOR a,... | Download Scientific Diagram](https://www.researchgate.net/publication/320108664/figure/fig3/AS:958807681269765@1605608973471/NorBNI-and-morphine-induce-ROS-production-via-JNK-and-PRDX6-MycKOR-a-c-or-mycMOR-b-d_Q640.jpg)
NorBNI and morphine induce ROS production via JNK and PRDX6. MycKOR a,... | Download Scientific Diagram
![Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3f21f1c4-4de7-4131-af58-bb484abd6473/jcpt12404-toc-0001-m.jpg?trick=1663733459430)
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
![N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-62530-w/MediaObjects/41598_2020_62530_Fig1_HTML.png)